Relentless. Passionate. Focused.

Kiniksa is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.

Our Story

Kiniksa has an experienced team with a track record delivering therapies to patients. We have numerous product-candidates in both clinical and preclinical development across a range of debilitating diseases with significant unmet medical need.

Our Strategy

Identify and rapidly develop product candidates with clear biology, validated mechanisms and the potential to deliver life-changing improvement to patients

PatientFocus

ClearBiology

Rare/SpecialtyDiseases

RapidDevelopment

GlobalVision

3

clinical stage molecules

1

planned pivotal study in a rare, debilitating disease

2

molecules preparing for IND-enabling studies

3+

research stage molecules

60+

employees committed to helping patients